Your browser doesn't support javascript.
loading
How prostate-specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway.
Ptasznik, Gideon; Kelly, Brian D; Murphy, Declan; Lawrentschuk, Nathan; Kasivisvanathan, Veeru; Page, Mark; Ong, Sean; Moon, Daniel.
Affiliation
  • Ptasznik G; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Kelly BD; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Murphy D; Young Urology Research Organisation, Melbourne, VIC, Australia.
  • Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Kasivisvanathan V; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Page M; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Ong S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Moon D; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
BJU Int ; 133 Suppl 3: 13-14, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37691457

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2024 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2024 Document type: Article Affiliation country: Australia Country of publication: United kingdom